The firm plans to enroll US patients into the trial of GEB-101 in the second quarter, having launched an investigator-initiated trial in China.

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S.

New Zealand’s health ministry will look into the cause of a cybersecurity breach ‍of a privately owned website, which hosts medical records for roughly a third of the country’s population and what ...

India has approved projects worth 418.63 billion rupees ($4.64 billion) from a host of companies ‍to boost domestic ...

If you've never light painted before, this is the video for you! Showing you the whole process from planning to shooting and then editing. Hopefully this explains the why and how for you. Thanks to ...

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...

Beam Therapeutics Inc. (NASDAQ: BEAM) is among the 12 Best Genomics Stocks to Invest In.

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

Anne Angeletti runs a jewelry business with her daughter and granddaughter. At 101 years old, Anne Angeletti is still deeply passionate about her life's work. She is constantly on the move, bustling ...